| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 106351-99-9 | Butanoic acid,2-[[4-[[(2,4-diamino-6-pteridinyl)methyl]amino]benzoyl]amino]-4-phosphono-; Butanoicacid, 2-[[4-[[(2,4-diamino-6-pteridinyl)methyl]amino]benzoyl]amino]-4-phosphono-,(?à)- |  | C18H21N8O6P | 詳情 | 供應商 | |
| 66761-26-0 | Guanosine5'-(tetrahydrogen triphosphate), P''-[5-azido-2-(hydroxymethyl)phenyl] ester(9CI) |  | C17H21N8O15P3 | 詳情 | 供應商 | |
| 81222-52-8 | L-Prolinamide,5-oxo-L-prolyl-2-diazonio-L-histidyl- (9CI); thyrotropin-releasing hormone, 2-diazohistidinyl- |  | C16H21N8O4+ | 詳情 | 供應商 | |
| 15475-56-6 | L-Glutamic acid,N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, sodium salt(1:?); Glutamicacid, N-[p-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, sodiumsalt, L-(+)- (8CI); L-Glutamic acid,N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, sodium salt(9CI); Abitrexate; Methotrexate sodium; Methotrexate sodium salt; SodiumL-(+)-methotrexate |  | C20H21N8NaO5 | 詳情 | 供應商 | |
| 113811-49-7 | Phosphonic acid,[2-[[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]amino]ethyl]-(9CI); [2-[4-[(2,4-Diaminopteridin-6-ylmethyl)(methyl)amino]benzoylamino]ethyl]phosphonicacid |  | C17H21N8O4P | 詳情 | 供應商 | |
| 93376-15-9 | 酸性棕 A | Acid Brown 440; Acid Brown 440; AcidBrownA; C.I.AcidBlack440; Brown PNR; C.I.Acid Brown 440 | 無 | C34H21N8Na3O14S3 | 詳情 | 供應商 |
| 229016-73-3 | PyridiniuM, 4-[2-[[(6R,7R)-2-carboxy-7-[[(2Z)-2-(ethoxyiMino)-2-[5-(phosphonoaMino)-1,2,4-thiadiazol-3-yl]acetyl]aMino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]thio]-4-thiazolyl]-1-Methyl-, inner salt; PyridiniuM, 4-[2-[[(6R,7R)-2-carboxy-7-[[(2Z)-2-(ethoxyiMino)-2-[5-(phosphonoaMino)-1,2,4-thiadiazol-3-yl]acetyl]aMino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]thio]-4-thiazolyl]-1-Methyl-, inner salt; Ceftaroline FosaMil Inner salt |  | C22H21N8O8PS4 | 詳情 | 供應商 |